(Q28203440)

1

0 references

Roberta Hanna

2

0 references

Della Friend

3

0 references

Heather Moore

4

0 references

Hongbo Chen

5

0 references

Ann M Farese

6

0 references

Thomas J MacVittie

7

0 references

G Duke Virca

8

0 references

John E Sims

Molecular characterization of murine and human OX40/OX40 ligand systems: identification of a human OX40 ligand as the HTLV-1-regulated protein gp34

9

0 references

language of work or name

English

0 references

publication date

January 2003

0 references

published in

Immunity

0 references

volume

18

0 references

issue

1

0 references

page(s)

87-96

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2802%2900514-9

7 January 2021

The inhibitory activity of human interleukin-1 receptor antagonist is enhanced by type II interleukin-1 soluble receptor and hindered by type I interleukin-1 soluble receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2802%2900514-9

7 January 2021

Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2802%2900514-9

7 January 2021

Anti-interleukin-1 therapy in rheumatic diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2802%2900514-9

7 January 2021

Interleukin-1, interleukin-1 receptors and interleukin-1 receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2802%2900514-9

7 January 2021

Prevention of collagen-induced arthritis with an antibody to gp39, the ligand for CD40

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2802%2900514-9

7 January 2021

Correlation of plasma interleukin 1 levels with disease activity in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2802%2900514-9

7 January 2021

Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2802%2900514-9

7 January 2021

Molecular cloning and characterization of a second subunit of the interleukin 1 receptor complex

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2802%2900514-9

7 January 2021

Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2802%2900514-9

7 January 2021

IL-1 signaling cascade in liver cells and the involvement of a soluble form of the IL-1 receptor accessory protein

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2802%2900514-9

7 January 2021

Elevated levels of soluble interleukin-1 receptor type II and interleukin-1 receptor antagonist in patients with chronic arthritis: correlations with markers of inflammation and joint destruction

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2802%2900514-9

7 January 2021

Interleukin-1 receptor accessory protein interacts with the type II interleukin-1 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2802%2900514-9

7 January 2021

Decoy receptors: a strategy to regulate inflammatory cytokines and chemokines

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2802%2900514-9

7 January 2021

A novel IL-1 receptor, cloned from B cells by mammalian expression, is expressed in many cell types

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2802%2900514-9

7 January 2021

Protection against a lethal dose of endotoxin by an inhibitor of tumour necrosis factor processing

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2802%2900514-9

7 January 2021

Further evidence for a common mechanism for shedding of cell surface proteins

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2802%2900514-9

7 January 2021

Role of Metalloproteases in the Release of the IL-1 type II Decoy Receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2802%2900514-9

7 January 2021

Interleukin 18 is a primary mediator of the inflammation associated with dextran sulphate sodium induced colitis: blocking interleukin 18 attenuates intestinal damage

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2802%2900514-9

7 January 2021

A single amino acid difference between human and monkey interleukin (IL)-1beta dictates effective binding to soluble type II IL-1 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2802%2900514-9

7 January 2021

Molecular cloning and expression of cynomolgus monkey interleukin-1beta cDNA.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2802%2900514-9

7 January 2021